Likelihood approach for evaluating bioequivalence of highly variable drugs.

about

Likelihood approach for evaluating bioequivalence of highly variable drugs.

Item

http://www.wikidata.org/entity/Q35786205

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@ast

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@en

type

Item

label

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@ast

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@en

prefLabel

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@ast

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@en

P1476

Likelihood approach for evaluating bioequivalence of highly variable drugs.

@en

P2093

Leena Choi

http://www.w3.org/2001/XMLSchema#string

Liping Du

http://www.w3.org/2001/XMLSchema#string

P2860

A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applications

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

A pure likelihood approach to the analysis of genetic association data: an alternative to Bayesian and frequentist analysis.

The Controversy over Generic Antiepileptic Drugs.

Likelihood methods for measuring statistical evidence.

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.

Bioequivalence approaches for highly variable drugs and drug products.

Evaluation of a scaling approach for the bioequivalence of highly variable drugs.

P304

82-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PST.1661

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25408492

http://www.w3.org/2001/XMLSchema#string

P932

4482106

http://www.w3.org/2001/XMLSchema#string